Audit and Research

The numbers of cataract surgeries performed, visual outcomes and posterior capsule rupture (PCR) rates are shown in Figures 1.1 to 1.3.

Benchmarks of success

Table 1.1 Outcomes of cataract surgery from international studies and at SNEC
Title of study	Country	Number of cases	BCVA 6/12 or better with ocular comorbidity
No (%) Yes (%)
The Cataract National Dataset electronic multi-centre audit of 55,567 operations: updating benchmark standards of care in the United Kingdom and internationally (laycock et al., 2009	UK	55,567	94.7	79.9
Determination of valid benchmarks for outcome indicators in cataract surgery: a multicentre, prospective cohort trial (Hanh et al., 2011)	Germany	1,685	98.5	-
Visual outcome of cataract surgery; study from the European Registry of Quality Outcomes for Cataract and Refractive Surgery (Lundstrom, Barry, Henry, Rosen, & Stenevi, 2013)	15 European countries	368,256	98.2	94.3
SNEC (main centre) 2014 audit data – phacoemulsification outcomes	Singapore	13,682	99.3	-

References

Hahn, U., Krummenauer, F., Kolbl, B., Neuhann, T., Schayan-Araghi, K., Schmickler, S., & Neuhann, I. (2011). Determination of valid benchmarks for outcome indicators in cataract surgery; a multicentre, prospective cohort trial. Ophthalmology, 118, 2105-2112.
Jaycock, P., Johnston, R. L., Taylor, H., Adams, M., Tole, D. M., Galloway, P., & Sparrow, J. M. (2009). The Cataract National Dataset electronic multi-centre audit of 55,567 operations: updating benchmark standards of care in the United Kingdom and internationally. Eye, 23, 38-49.
Lundstrom, M., Barry, P., Henry, Y., Rosen, P., & Stenevi, U. (2013). Visual outcome of cataract surgery; study from the European Registry of Quality Outcomes for Cataract and Refractive Surgery. Journal of Cataract & Refractive Surgery, 39, 673-679.

Our Care Team

Back to Clinical Interests

Our Care Team

News

Announcements S’pore institute in $21m tie-up to develop treatments for eye diseases SERI and Santen has launched SONIC 2.0, a $21 million initiative to develop treatments for eye diseases like glaucoma and myopia. The three-year collaboration builds on SONIC 1.0, which resulted in 13 research projects and the development of low-dose atropine drops for myopia. SONIC 2.0 aims to develop two treatments to the clinical stage, expand the use of ophthalmic drugs and contribute to Singapore's biomedical innovation.

04 Dec 2025 | The Straits Times Read Story

Patient Care Redness, 'panda eyes', sagging lids: How to get rid of cosmetic side effects due to glaucoma drops

12 Mar 2023 | The Straits Times Read Story

View All